High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Open Access
- 22 November 2009
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 98 (1) , 117-123
Abstract
Atypical Teratoid/Rhabdoid tumors (AT/RT) of the central nervous system are rare but aggressive tumors of childhood. Median survival with surgery and standard chemotherapy is less than 12 months. In an attempt to improve outcome, patients were treated with aggressive surgical resection and multi-agent chemotherapy, followed by high dose chemotherapy with autologous stem cell rescue. Nine consecutive children (median age 21 months) were diagnosed with AT/RT at the University of California San Francisco Childrens Hospital from 1997 to 2007 and treated with this aggressive approach. Diagnosis was confirmed using molecular markers. There are two long-term survivors (78 and 98 months from diagnosis). One additional patient is alive with disease. Three patients died of disease during therapy. Three patients died of disease after therapy was complete. There were no toxic deaths. Two of nine patients treated for AT/RT at our institution with high dose chemotherapy and autologous bone marrow transplant are long-term survivors, suggesting that a subset of patients can be cured with this approach.Keywords
This publication has 25 references indexed in Scilit:
- Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid TumorJournal of Clinical Oncology, 2009
- Insulin and insulin-like growth factor signalling in neoplasiaNature Reviews Cancer, 2008
- Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumorsPediatric Blood & Cancer, 2008
- Immunohistochemistry of INI1 Expression: A New Tool for Old Challenges in CNS and Soft Tissue PathologyAdvances in Anatomic Pathology, 2007
- Novel role for insulin as an autocrine growth factor for malignant brain tumour cellsBiochemical Journal, 2007
- Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cellsEuropean Journal of Cancer, 2007
- Congenital Disseminated Malignant Rhabdoid Tumor and Cerebellar Tumor Mimicking Medulloblastoma in Monozygotic TwinsAmerican Journal of Surgical Pathology, 2002
- Successful Treatment of Disseminated Central Nervous System Malignant Rhabdoid TumorJournal of Pediatric Hematology/Oncology, 1995
- Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhoodJournal of Neuro-Oncology, 1995
- Rhabdoid tumor of the central nervous systemMedical and Pediatric Oncology, 1992